Literature DB >> 28815024

Stem cell-derived organoids to model gastrointestinal facets of cystic fibrosis.

Meike Hohwieler1, Lukas Perkhofer1, Stefan Liebau2, Thomas Seufferlein1, Martin Müller1, Anett Illing1, Alexander Kleger1.   

Abstract

Cystic fibrosis (CF) is one of the most frequently occurring inherited human diseases caused by mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) which lead to ample defects in anion transport and epithelial fluid secretion. Existing models lack both access to early stages of CF development and a coeval focus on the gastrointestinal CF phenotypes, which become increasingly important due increased life span of the affected individuals. Here, we provide a comprehensive overview of gastrointestinal facets of CF and the opportunity to model these in various systems in an attempt to understand and treat CF. A particular focus is given on forward-leading organoid cultures, which may circumvent current limitations of existing models and thereby provide a platform for drug testing and understanding of disease pathophysiology in gastrointestinal organs.

Entities:  

Keywords:  Pancreas development; cystic fibrosis; induced pluripotent stem cells; organoids; stem cells

Year:  2016        PMID: 28815024      PMCID: PMC5548342          DOI: 10.1177/2050640616670565

Source DB:  PubMed          Journal:  United European Gastroenterol J        ISSN: 2050-6406            Impact factor:   4.623


  131 in total

1.  Functional engraftment of colon epithelium expanded in vitro from a single adult Lgr5⁺ stem cell.

Authors:  Shiro Yui; Tetsuya Nakamura; Toshiro Sato; Yasuhiro Nemoto; Tomohiro Mizutani; Xiu Zheng; Shizuko Ichinose; Takashi Nagaishi; Ryuichi Okamoto; Kiichiro Tsuchiya; Hans Clevers; Mamoru Watanabe
Journal:  Nat Med       Date:  2012-03-11       Impact factor: 53.440

Review 2.  Update in cystic fibrosis 2012.

Authors:  Christopher H Goss; Felix Ratjen
Journal:  Am J Respir Crit Care Med       Date:  2013-05-01       Impact factor: 21.405

3.  Pancreatic damage in fetal and newborn cystic fibrosis pigs involves the activation of inflammatory and remodeling pathways.

Authors:  Maisam Abu-El-Haija; Shyam Ramachandran; David K Meyerholz; Marwa Abu-El-Haija; Michelle Griffin; Radhamma L Giriyappa; David A Stoltz; Michael J Welsh; Paul B McCray; Aliye Uc
Journal:  Am J Pathol       Date:  2012-06-08       Impact factor: 4.307

4.  High level of CFTR expression is associated with tumor aggression and knockdown of CFTR suppresses proliferation of ovarian cancer in vitro and in vivo.

Authors:  Jiao Xu; Min Yong; Jia Li; Xiaojing Dong; Tinghe Yu; Xiao Fu; Lina Hu
Journal:  Oncol Rep       Date:  2015-03-03       Impact factor: 3.906

5.  Circulating tumor necrosis factor-alpha levels and lipid abnormalities in patients with cystic fibrosis.

Authors:  E Levy; C Gurbindo; F Lacaille; K Paradis; L Thibault; E Seidman
Journal:  Pediatr Res       Date:  1993-08       Impact factor: 3.756

6.  Mechanism-based corrector combination restores ΔF508-CFTR folding and function.

Authors:  Tsukasa Okiyoneda; Guido Veit; Johanna F Dekkers; Miklos Bagdany; Naoto Soya; Haijin Xu; Ariel Roldan; Alan S Verkman; Mark Kurth; Agnes Simon; Tamas Hegedus; Jeffrey M Beekman; Gergely L Lukacs
Journal:  Nat Chem Biol       Date:  2013-05-12       Impact factor: 15.040

7.  Genetic modifiers of liver disease in cystic fibrosis.

Authors:  Jaclyn R Bartlett; Kenneth J Friedman; Simon C Ling; Rhonda G Pace; Scott C Bell; Billy Bourke; Giuseppe Castaldo; Carlo Castellani; Marco Cipolli; Carla Colombo; John L Colombo; Dominique Debray; Adriana Fernandez; Florence Lacaille; Milan Macek; Marion Rowland; Francesco Salvatore; Christopher J Taylor; Claire Wainwright; Michael Wilschanski; Dana Zemková; William B Hannah; M James Phillips; Mary Corey; Julian Zielenski; Ruslan Dorfman; Yunfei Wang; Fei Zou; Lawrence M Silverman; Mitchell L Drumm; Fred A Wright; Ethan M Lange; Peter R Durie; Michael R Knowles
Journal:  JAMA       Date:  2009-09-09       Impact factor: 56.272

8.  Characterization of defects in ion transport and tissue development in cystic fibrosis transmembrane conductance regulator (CFTR)-knockout rats.

Authors:  Katherine L Tuggle; Susan E Birket; Xiaoxia Cui; Jeong Hong; Joe Warren; Lara Reid; Andre Chambers; Diana Ji; Kevin Gamber; Kengyeh K Chu; Guillermo Tearney; Li Ping Tang; James A Fortenberry; Ming Du; Joan M Cadillac; David M Bedwell; Steven M Rowe; Eric J Sorscher; Michelle V Fanucchi
Journal:  PLoS One       Date:  2014-03-07       Impact factor: 3.240

9.  A network of epigenetic regulators guides developmental haematopoiesis in vivo.

Authors:  Hsuan-Ting Huang; Katie L Kathrein; Abby Barton; Zachary Gitlin; Yue-Hua Huang; Thomas P Ward; Oliver Hofmann; Anthony Dibiase; Anhua Song; Svitlana Tyekucheva; Winston Hide; Yi Zhou; Leonard I Zon
Journal:  Nat Cell Biol       Date:  2013-11-17       Impact factor: 28.824

10.  Human intestinal tissue with adult stem cell properties derived from pluripotent stem cells.

Authors:  Ryan Forster; Kunitoshi Chiba; Lorian Schaeffer; Samuel G Regalado; Christine S Lai; Qing Gao; Samira Kiani; Henner F Farin; Hans Clevers; Gregory J Cost; Andy Chan; Edward J Rebar; Fyodor D Urnov; Philip D Gregory; Lior Pachter; Rudolf Jaenisch; Dirk Hockemeyer
Journal:  Stem Cell Reports       Date:  2014-06-03       Impact factor: 7.765

View more
  8 in total

1.  Updates in Pediatric Pancreatology: Proceedings of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition Frontiers in Pediatric Pancreatology Symposium.

Authors:  Amit S Grover; Alvin J Freeman; Maisam Abu-El-Haija; John F Eisses; Timothy B Gardner; Quin Y Liu; Mark E Lowe; Jaimie D Nathan; Tonya M Palermo; Vikesh K Singh; Andrew T Trout; Aliye Uc; Sohail Z Husain; Veronique D Morinville
Journal:  J Pediatr Gastroenterol Nutr       Date:  2019-02       Impact factor: 2.839

Review 2.  Advancing precision medicine with personalized drug screening.

Authors:  Kirill Gorshkov; Catherine Z Chen; Raisa E Marshall; Nino Mihatov; Yong Choi; Dac-Trung Nguyen; Noel Southall; Kevin G Chen; John K Park; Wei Zheng
Journal:  Drug Discov Today       Date:  2018-08-17       Impact factor: 7.851

3.  Pancreatic cancer-derived organoids - a disease modeling tool to predict drug response.

Authors:  Pierre-Olivier Frappart; Karolin Walter; Johann Gout; Alica K Beutel; Mareen Morawe; Frank Arnold; Markus Breunig; Thomas Fe Barth; Ralf Marienfeld; Lucas Schulte; Thomas Ettrich; Thilo Hackert; Michael Svinarenko; Reinhild Rösler; Sebastian Wiese; Heike Wiese; Lukas Perkhofer; Martin Müller; André Lechel; Bruno Sainz; Patrick C Hermann; Thomas Seufferlein; Alexander Kleger
Journal:  United European Gastroenterol J       Date:  2020-02-19       Impact factor: 4.623

4.  Reprogramming to pluripotency does not require transition through a primitive streak-like state.

Authors:  Stefanie Raab; Moritz Klingenstein; Anna Möller; Anett Illing; Jelena Tosic; Markus Breunig; Georg Kuales; Leonhard Linta; Thomas Seufferlein; Sebastian J Arnold; Alexander Kleger; Stefan Liebau
Journal:  Sci Rep       Date:  2017-11-29       Impact factor: 4.379

Review 5.  Approaching two decades of cystic fibrosis research in Qatar: a historical perspective and future directions.

Authors:  Samer Hammoudeh; Wessam Gadelhak; Atqah AbdulWahab; Mona Al-Langawi; Ibrahim A Janahi
Journal:  Multidiscip Respir Med       Date:  2019-10-01

6.  Transcriptional changes and the role of ONECUT1 in hPSC pancreatic differentiation.

Authors:  Sandra Heller; Zhijian Li; Qiong Lin; Ryan Geusz; Markus Breunig; Meike Hohwieler; Xi Zhang; Gopika G Nair; Thomas Seufferlein; Matthias Hebrok; Maike Sander; Cécile Julier; Alexander Kleger; Ivan G Costa
Journal:  Commun Biol       Date:  2021-11-17

Review 7.  Human Pluripotent Stem Cells Go Diabetic: A Glimpse on Monogenic Variants.

Authors:  Sandra Heller; Michael Karl Melzer; Ninel Azoitei; Cécile Julier; Alexander Kleger
Journal:  Front Endocrinol (Lausanne)       Date:  2021-05-17       Impact factor: 5.555

Review 8.  Current strategies and opportunities to manufacture cells for modeling human lungs.

Authors:  Ratna Varma; John P Soleas; Thomas K Waddell; Golnaz Karoubi; Alison P McGuigan
Journal:  Adv Drug Deliv Rev       Date:  2020-08-22       Impact factor: 15.470

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.